62 results
Page 2 of 4
8-K
EX-99.2
1fb30bjv2y00ih
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-99.2
li0lap66q4c1l19d6qk
29 Mar 21
Business combination disclosure
7:27am
8-K
EX-99.2
tnyq3nov 5r7auwrh
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
EX-99.1
8m3xfzf
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
EX-99.2
uukvck
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
EX-99.1
91qlrl
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
8-K
EX-99.1
xqordh2ypka8rx7j
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
rqnmd1
19 Dec 19
Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
8:31am
8-K
EX-99.1
hmyiy1vudo8ldzk gp
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
8-K
EX-99.1
uwwh 4ec74m
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
EX-99.1
fxqori8 oq2
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
8-K
EX-99.1
g8l t5ev7fqx022eqo0f
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm